Westlake Pharmaceuticals (Hangzhou) Co., Ltd.
4 clinical trials · Sponsor
◉ Watch Westlake Pharmaceuticals (Hangzhou) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| [14C] Study to Investigate the Mass Balance and Biotransformation of WPV01 in Healthy Adult Chinese Male Participants (NCT07080658) | Westlake Pharmaceuticals (Hangzhou) Co., Ltd. | 2023-07-23 |
| Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19 (NCT06197217) | Westlake Pharmaceuticals (Hangzhou) Co., Ltd. | 2023-06-14 |
| Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection (NCT05752175) | Westlake Pharmaceuticals (Hangzhou) Co., Ltd. | 2023-03-10 |
| Study of WPV01 in Healthy Subjects (NCT06205329) | Westlake Pharmaceuticals (Hangzhou) Co., Ltd. | 2022-10-03 |
Track Westlake Pharmaceuticals (Hangzhou) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.